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Abstract
Background: The Notch signalling pathway plays an essential role in mucosal regeneration, which 
constitutes a key goal of Crohn’s disease (CD) treatment. Macrophages coordinate tissue repair 
and several phenotypes have been reported which differ in the expression of surface proteins, 
cytokines and hypoxia-inducible factors (HIFs). We analysed the role of HIFs in the expression of 
Notch ligands in macrophages and the relevance of this pathway in mucosal regeneration.
Methods: Human monocytes and U937-derived macrophages were polarized towards the M1 
and M2 phenotypes and the expression levels of HIF-1α, HIF-2α, jagged 1 (Jag1) and delta-like 4 
(Dll4) were evaluated. The effects of macrophages on the expression of HES1 (the main target of 
Notch signalling) and IAP (enterocyte marker) in epithelial cells in co-culture were also analysed. 
Phenotype macrophage markers and Notch signalling were evaluated in the mucosa of CD patients.
Results: M1 macrophages were associated with HIF-1-dependent induction of Jag1 and Dll4, 
which increased HES1 protein levels and IAP activity in co-cultured epithelial cells. In the mucosa 
of CD patients a high percentage of M1 macrophages expressed both HIF-1α and Jag1 while M2 
macrophages mainly expressed HIF-2α and we detected a good correlation between the ratio of 
M1/M2 macrophages and both HES1 and IAP protein levels.
Conclusion: M1, but not M2, macrophages are associated with HIF-1-dependent induction of Notch 
ligands and activation of epithelial Notch signalling pathway. In the mucosa of chronic CD patients, 
the prevalence of M2 macrophages is associated with diminution of Notch signalling and impaired 
enterocyte differentiation.
Key Words:  Macrophages; Crohn’s disease; mucosal healing; Notch signalling
1. Introduction
Crohn’s disease (CD) is a chronic relapsing inflammatory disorder 
of the gastrointestinal tract characterized by transmural inflamma-
tion, architectural distortion and thickening of all the layers of the 
bowel wall, which leads to intestinal fibrosis and stricture develop-
ment.1 The aim of current clinical management is to prolong periods 
of remission and halt the destructive and progressive course of the 
disease. In recent years mucosal healing has been established as a key 
treatment goal in CD that predicts sustained clinical remission and 
resection-free survival of patients.2,3 This process is highly depend-
ent on the adequate reconstruction of the intestinal epithelium, 
which depends on proliferation and differentiation of the progenitor 
cells located at the base of the crypts. The coordination of several 
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signalling pathways, including Wnt and Notch, plays an essential 
role in epithelial regeneration.4–10
The Notch signalling pathway is mediated by Notch proteins, 
which act as receptors for the transmembrane ligands Jagged 
(Jag) and Delta-like (Dll) proteins. Upon binding to their ligands, 
Notch receptors are cleaved by γ-secretase and the Notch intracel-
lular domain translocates to the nucleus, where it up-regulates the 
expression of specific target genes, such as HES1. This gene, in turn, 
represses the expression of Math1, a master regulator of secretory cell 
lineage differentiation.6,7 It was initially reported that deletion of the 
HES1 gene resulted in the generation of an excessive number of secre-
tory cells.11 Later studies demonstrated that inactivation of Notch 
signalling results in conversion of proliferating progenitors into 
post-mitotic goblet cells,12 which led to the assumption that Notch 
signalling plays an essential role in regulating cell-fate decisions in 
intestinal homeostasis. However, there is still controversy regard-
ing the regulation of Notch signalling in CD. An increase in Math1 
mRNA expression has been reported in the damaged mucosa of CD 
patients13 while increased cleavage of Notch-1, which is the upstream 
signal regulating HES1 expression, has also been described.14
Macrophages constitute one of the central components of the 
inflamed mucosa, where local hypoxia and inflammatory mediators 
modulate their gene expression through the activity of hypoxia-induc-
ible factors (HIFs).15,16 Several macrophage phenotypes have been 
characterized, and differ in the expression of surface proteins and the 
production of cytokines.17 The M1 or pro-inflammatory phenotype 
mediates the defence of the host from microorganisms and contrib-
utes to inflammatory injury. There is evidence in the literature of a role 
for the transcription factor HIF-1 in M1 polarization,18 and several 
studies report the up-regulation of Notch receptors and Notch signal-
ling in classical macrophage differentiation.19–21 The M2 macrophage 
phenotype expresses high levels of anti-inflammatory cytokines and 
coordinates tissue repair.22,23 It has recently been reported that inhibi-
tion of Notch signalling enhances M2 polarization.20 In the present 
study we analysed the role of HIF in the expression of Notch ligands 
in macrophages. In addition, taking into account the strategic posi-
tion of macrophages in maintaining communication with epithelial 
cells, we explored the relevance of macrophages in the regulation of 
Notch signalling and regeneration of the mucosa of CD patients.
2. Materials and methods
2.1. Intestinal mucosal samples
Colonic surgical resections were obtained from the damaged mucosa 
of CD patients and from the healthy mucosa of patients with colo-
rectal cancer (as controls) (Table 1). The study was approved by the 
Institutional Review Board of The Hospital of Manises (Valencia). 
Written informed consent was obtained from all participating patients.
2.2. Isolation of colonic crypts
Human intestinal crypts were isolated from the mucosa of surgical resec-
tions obtained from control and CD patients, as described previously.24
2.3. Isolation of macrophages from human intestine
Macrophages were isolated from the mucosa of surgical resections 
obtained from control and CD patients as described previously.24
2.4. Cell culture
Caco-2 cells (American Type Culture Collection, VA) were cultured 
in MEM medium (Sigma-Aldrich) supplemented with 20% inacti-
vated foetal bovine serum (FBS) with 100 Um/L penicillin, 100 mg/
mL streptomycin, 2 mM l-glutamine (Lonza), 100 mM sodium pyru-
vate (Lonza) and 1% non-essential amino acids (Lonza).
HT29 cells (American Type Culture Collection, VA, USA) were 
cultured in McCoy’s Medium Modified (Sigma-Aldrich) supple-
mented with 10% inactivated FBS, 100 U/mL penicillin, 100 μg/mL 
streptomycin and 2 mM l-glutamine.
Human monocytes (U937, European Collection of Cell Culture, 
Salisbury, UK) were cultured in RPMI medium with 10% inacti-
vated FBS with 100 U/mL penicillin and 100 μg/mL streptomycin. 
Monocytes were differentiated into macrophages by culturing them 
in the presence of phorbol myristate acetate (PMA) for 48 h.25 U937-
derived macrophages were stimulated with lipopolysaccharide (LPS; 
0.1 µg/mL; E. coli 0111:B4) and interferon γ (IFN-γ; 20 ng/mL) or 
with interleukin 4 (IL-4; 20 ng/mL) in order to polarize them towards 
M1 or M2 phenotypes, respectively, as previously reported.26
Hypoxia (3% O2) was established by incubating macrophages 
in a CO2/O2 incubator (Invivo2 400, Ruskinn Technology Ltd, 
Pencoed, UK) with a blend of 5% CO2 and the appropriate per-
centages of O2 and N2 to a total of 100%. Normoxic controls were 
obtained by incubating the cells at 21% O2.
2.5. Isolation of mononuclear cells
Human peripheral blood mononuclear cells were isolated from both 
healthy donors and CD patients by Ficoll density-gradient centrifu-
gation at 400g for 40 minutes. Monocyte-derived macrophages were 
obtained from monocytes seeded in 12-well tissue culture plates and 
differentiated into macrophages by culture in X-Vivo 15 medium 
(Lonza) supplemented with 1% human serum, 100 U/mL penicillin, 
100 μg/mL streptomycin and 20 ng/mL recombinant human mac-
rophage colony-stimulating factor (M-CSF, Peprotech, London, UK) 
at 37ºC in 5% CO2 for 6 days.
2.6. Co-culture
U937-derived macrophages were seeded and differentiated as above. 
Afterwards the epithelial cells were placed in the same wells at a 
ratio 1:1 and were maintained in co-culture for 24 hours.
2.7. Alkaline phosphatase activity
Following 24 hours of co-culture with macrophages, cells were 
washed with cold phosphate-buffered saline (PBS) and lysed in 
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Table 1. Patient characteristics.
Patient group and characteristic n
Crohn’s disease 16
 Age (y)
  17–40 6
  >40 10
 Gender
  Male 9
  Female 7
 Concomitant medication
  Azathioprine 3
  Anti-tumour necrosis factor 16
  Mesalazine 2
Control 11
 Age (y)
  17–40 0
  >40 11
 Gender
  Male 7
  Female 4
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150 μL of 0.5% Triton X-100, 10 mM Tris–HCl (pH 8) and 150 mM 
NaCl. Each sample was mixed with a p-nitrophenyl phosphate solu-
tion (Sigma-Aldrich). Thirty minutes later, absorbance at 405 nm 
was measured. Protein content was quantified using the Bradford 
assay (Bio-Rad Laboratories, Madrid, Spain). Alkaline phosphatase 
activity was also determined in macrophages cultured alone.
2.8. Immunohistochemistry, immunofluorescence 
and goblet cell count
Immunohistochemistry for HES1, CD68, CD86 and CD206 cells 
was performed in 5  µm sections of paraffin-embedded tissues 
(Table 2). A horse anti-mouse/rabbit biotinylated antibody (Vector 
Laboratories, CA, USA, 1:200) was used as a secondary antibody as 
previously described.26 An area of 0.3 mm2 was selected for quantita-
tive analysis.
Goblet cells were counted following standard periodic acid–Schiff 
staining of the sections adjacent to those used for immunostaining. 
We counted the number of goblet cells (by counting the vacuoles) in at 
least three crypts per sample and results were normalized to the total 
number of epithelial cells (by counting the nuclei) in the same crypt.
2.9. Static cytometry
Macrophages isolated from the mucosa of surgical resections 
obtained from control and CD patients were fixed with 2% para-
formaldehyde, permeabilized with 0.1% Triton-X100 and double-
stained (Jag1/CD86, Jag1/CD206, HIF1α/CD86, HIF1α/CD206, 
HIF2α/CD86, HIF2α/CD206, CD86/CD68, CD206/CD68, arginase 
I/CD68, iNOs/CD68) with specific monoclonal antibodies (Table 2) 
as previously described.24 Fluorescence-labelled (TR and FITC) goat 
anti-mouse or goat anti-rabbit (1:100, Santa Cruz Biotechnology) 
was used as the secondary antibody, and Hoechst 33342 was added 
to stain the nuclei.
U937 macrophages co-cultured with epithelial cells were incu-
bated overnight at 4ºC with monoclonal antibodies against HES1 
or Muc2 combined with an antibody against CD18 to identify 
and exclude macrophages from the cytometric analysis (Table  2). 
Fluorescence-labelled (TR and FITC) goat anti-mouse or goat anti-
rabbit (1:100, Santa Cruz Biotechnology) were used as the secondary 
antibodies, and Hoechst 33342 was added to stain the nuclei. In 
all cases the fluorescent signal (16 images per well) was quantified 
using the static cytometer software Scan® version 2.03.2 (Olympus, 
Barcelona, Spain).
2.10. RNA interference and cellular transfection
U937 cells were transfected with a vector targeting human HIF-
1α (miHIF-1α, described previously27) or a non-targeting con-
trol vector (mock), as described previously.27 In addition, we 
have now designed vectors targeting human Jag1 (miJag1; 
28.82 ± 15.70% of reduction vs mock, based on the targeting 
sequence 5ʹ-CCTAAGCATGGGTCTTGCAAA-3ʹ; GenBank acces-
sion number NM_000214.2) and Dll4 (miDll4; 27.74 ± 13.39% 
of reduction vs mock, based on the targeting sequence 
5ʹ-TCCAACTGCCCTTCAATTTCA-3ʹ; GenBank accession number 
NM_019074.3). Lipofectamine-2000 (Invitrogen Life Technologies, 
Carlsbad, CA) was employed as a transfection reagent according to 
the manufacturer’s instructions. Twenty-four hours post-transfec-
tion, cells were incubated for 8 h in normoxic or hypoxic conditions, 
as described above. M1 macrophages were transfected with miHIF-
1α, miJag1, miDll4 or a mock vector before M1 polarization.
2.11. Protein extraction and Western blot analysis
Equal amounts of protein from macrophages, HT29 cells, Caco-2 
cells or colonic tissue28 were loaded onto sodium dodecyl sulphate/
polyacrylamide gel electrophoresis gels and analysed by Western blot 
as described previously (Table 2). Protein expression was quantified 
by means of densitometry using Image Gauge Version 4.0 software 
(Fujifilm). Data were normalized to β-actin.
2.12. RNA extraction and quantitative reverse 
transcription–polymerase chain reaction (qRT-PCR) 
analysis
Total RNA and cDNA from macrophages or colonic tissue was 
obtained as described previously.25 Real-time PCR was performed 
with the PrimeScript Reagent Kit Perfect Real Time (Takara) in a 
thermocycler (LightCycler, Roche Diagnostics). Specific oligonucleo-
tides were designed according to the sequences shown in Table 3.
2.13. Chromatin immunoprecipitation (ChIP) assay
A ChIP assay was carried out in U937-derived macrophages, 
incubated under hypoxia or normoxia for 5 h, as previously 
described.25 Immunoprecipitation was performed with anti-
HIF1α antibody (BD, Madrid, Spain) or control IgG antibody. 
After reverse crosslinking, DNA fragments were purified with a 
Montage PCR Kit (Millipore, Germany). PCR was performed 
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Table 2. Specific antibodies used for immunohistochemistry, immunofluorescence studies and Western blot analysis.
Antibody Immunofluorescence Immunohistochemistry Western blot
Antibody dilution Antigen retrieval Antibody dilution
IAP (Santa Cruz Biotechnology) 1:1000
HES1 (Santa Cruz Biotechnology) 1:100 Sodium citrate buffer pH 6°C, 20 min, 1:200 1:500
Jag1 (Santa Cruz Biotechnology) 1:100 Sodium citrate buffer pH 9°C, 20 min, 1:200
CD18 (BD, Barcelona Spain) 1:100
CD68 (Biolegend, Madrid, Spain) 1:100 α-Chymotrypsin 37°C, 20 min, 1:100
CD86 (Epitomics, Burlingame, CA, USA) 1:100 α-Chymotrypsin 37°C, 20 min, 1:200
CD206 (Novus Biologicals, Cambridge, UK) 1:100 Sodium citrate buffer pH 9°C, 20 min, 1:200
Arginase I (Santa Cruz Biotechnology) 1:100
iNOs (Santa Cruz Biotechnology) 1:100
HIF-1α (Novus Biologicals) 1:100 1:500
HIF-2α (Santa Cruz Biotechnology) 1:100
Muc2 (Santa Cruz Biotechnology) 1:100
β-actin (Sigma-Aldrich) 1:10 000
AQ12
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using PCR Master (Roche Diagnostics, Mannheim, Germany) 
with the primers 5ʹ-TGTCCACCCTTCAAAGGAAGTC-3ʹ and 
5ʹ-CAAATCCGAGTCTGCGGAGC-3ʹ, detecting the region −1646 
to −1166 in the Jag1 promoter, or 5ʹ-CCCTGAGCATCCCGCTG-3ʹ 
and 5ʹ-CCGGCTCTAATATACTCCGCC-3ʹ, detecting the region 
−638 to −106 in the Jag1 promoter, as shown in Figure 1c. The PCR 
products were separated by electrophoresis in 2% agarose gel.
2.14. Statistical analysis
Data were expressed as mean ± SEM and compared by one-way 
analysis of variance (ANOVA) with Newman–Keuls post hoc cor-
rection for multiple comparisons or a t-test when appropriate. A p 
value <0.05 was considered to be statistically significant. Clinical 
correlations were analysed in the human samples using Pearson’s 
correlation coefficient.
3. Results
3.1. HIF-1 mediates the expression of Notch ligands 
in M1 macrophages
Hypoxia induced a time-dependent increase in HIF-1α stabilization 
in macrophages, which peaked at 8 hours and then progressively 
decreased. In parallel, hypoxia induced a time-dependent increase in 
the mRNA expression of Jag1 and Dll4 compared with the expres-
sion detected in cells in normoxia (Figure 1a). To evaluate the role of 
HIF-1 in gene expression, we used an miRNA approach to selectively 
knockdown this transcription factor in U937-derived macrophages. 
As shown in Figure 1b, up-regulation of the mRNA expression of 
both Dll4 and Jag1 induced by hypoxia was significantly reduced in 
cells transfected with miHIF1α, showing that HIF-1 is involved in 
the induction of these ligands in hypoxia.
Analysis of the Jag1 gene promoter identified potential HIF-1 
binding sites (HRE sequence). To examine the binding of HIF-1α 
to the promoter region of Jag1, we performed ChIP assays using 
an affinity-purified antibody directed against HIF-1α and primers 
specific for two Jag1 promoter regions containing HIF-1 binding 
sites (Figure  1c). Our data revealed HIF-1α binding to the proxi-
mal promoter region of the Jag1 gene in hypoxia through the HRE 
sequences located between positions −106 and −638 (Figure  1c) 
from the start codon.
Polarization of U937 macrophages towards an M1 phenotype26 
following treatment with LPS + IFN induced HIF-1α stabilization 
within the first 24 hours and failed to induce HIF-2α stabilization 
significantly at any time analysed (Figure  2a). In contrast, polari-
zation towards an M2 phenotype26 as a result of treatment with 
IL-4 induced HIF-2α stabilization but not HIF-1α stabilization 
(Figure 2a). Analysis of the expression of HIF-1 target genes revealed 
a significant increase (fold induction) in the mRNA expression of 
LDHA (2.2 ± 0.4) and iNOS (6.0 ± 1.7) by M1 macrophages com-
pared with both non-polarized (1.0 ± 0.2 and 0.9 ± 0.1, respectively) 
and M2 (1.2 ± 0.3 and 2.4 ± 1.3, respectively) macrophages. In addi-
tion, the expression of an HIF-2 target gene, ArgI, was increased in 
M2 macrophages (2.7 ± 0.7) compared with non-polarized (1.0 ± 0.1) 
and M1 (0.8 ± 0.1) cells. Analysis of the expression of Notch ligands 
revealed a significant increase in mRNA expression of Dll4 and 
mRNA expression and protein levels of Jag1 in M1 macrophages 
but not in M2 cells (Figure 2b). These effects were also observed in 
macrophages derived from primary monocytes obtained from both 
healthy donors and CD patients (Figure 2c). The up-regulation of the 
mRNA expression of both Dll4 and Jag1 that was detected in U-937 
macrophages polarized towards an M1 phenotype was significantly 
reduced in cells transfected with miHIF1α (Figure 2d), demonstrat-
ing that HIF-1 is involved in the induction of Notch ligands in M1 
macrophages.
3.2. HIF-1-dependent induction of Notch ligands 
mediates the increase in HES1 expression and IAP 
activity induced by M1 macrophages
Next we analysed whether macrophages modulate the Notch signal-
ling pathway and markers of differentiation in co-cultured epithelial 
cells. First, we determined the expression of HES1 and IAP (a marker 
of enterocyte differentiation) protein levels in two epithelial cell lines, 
HT29 and Caco-2, at sub-confluence and at different times after 
reaching cell confluence. Our data show a time-dependent increase 
in protein levels of both HES1 and IAP as well as IAP enzymatic 
activity in both HT29 and Caco-2 cells by culturing post-confluence 
(Supplementary Figure 1).
In the co-culture experiments, M1 macrophages increased pro-
tein levels of HES1 and IAP enzymatic activity with no effect on 
Muc2 expression in either HT29 or Caco-2 cells (Figure  3a–d). 
The effects induced by M1 macrophages on epithelial protein lev-
els of HES1 were significantly reduced in macrophages treated with 
miHIF1, miDLL4 and miJag1, suggesting that the HIF-1-dependent 
induction of Notch ligands mediates the activation of Notch signal-
ling in epithelial cells (Figure 3a, c). In contrast, M2 macrophages 
did not significantly modify HES1 protein levels but induced a sig-
nificant reduction in IAP activity in both HT29 and Caco-2 cells 
(Figure 3a–d). No IAP activity was detected in macrophages.
3.3. M1 macrophages express HIF-1α and Notch 
ligands while M2 macrophages express HIF-2α in 
the mucosa of CD patients
Next we performed a comparative study of control and CD patients 
to characterize the macrophage phenotype present in the mucosa 
of CD patients and the expression of HIF and Notch ligands in 
these cells.
Immunohistochemical experiments revealed macrophages in an 
adjacent position to epithelial cells (Figure  4a) and a quantitative 
analysis showed that the numbers of CD68+ cells and CD206+ cells 
were significantly higher in the mucosa of chronic CD patients than 
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Table 3. Primer sequences of specific PCR products for each gene analysed.
Human gene Sense Antisense Length (bp)
Jag1 5ʹ-gaacacgggcgttgcccact-3ʹ 5ʹ-gtggacgcatcccgggtgtg-3ʹ 304
Dll4 5ʹ-gtgcagcgtacaccggcact-3ʹ 5ʹ- tctgttcgcgacgccgcttt-3ʹ 223
HES1 5ʹ-aaaattcctcgtccccggtg-3ʹ 5ʹ-tttgt tatccgttcg-3ʹ 64
Muc2 5ʹ-gctggccgccggctattacc-3ʹ 5ʹ-accccggccgtcatccatca-3ʹ 79
Math1 5ʹ-ccgcccagtatttgctacat-3ʹ 5ʹ-cattcacctgtttgctggaa-3ʹ 234
β-actin 5ʹ-ggacttcgagcaagagatgg-3ʹ 5ʹ-agcactgtgttggcgtacag-3ʹ 67
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in that of control patients. In contrast, no significant differences 
were observed in the number of CD86+ cells (Figure 4b). Double 
immunofluorescence experiments in macrophages isolated from the 
mucosa revealed that the percentage of CD68-positive cells that 
expressed M1 markers CD86 and iNOS was similar in CD and con-
trol patients. In contrast, the percentage of CD68-positive cells that 
expressed M2 markers CD206 and ArgI was significantly higher in 
macrophages isolated from the mucosa of CD patients (Figure 4c).
We also detected a high percentage of CD86+ cells expressing 
HIF-1α in macrophages isolated from both control and CD patients, 
while a very low percentage of CD206+ cells expressed HIF-1α 
(Figure 5b). In contrast, a large percentage of CD206+ cells from 
the mucosa of both control and CD patients expressed HIF-2α while 
a low percentage of CD86+ cells expressed HIF-2α (Figure  5c). 
Finally, the percentage of cells expressing the Notch ligand Jag1 in 
the population of CD86+ cells was higher than that recorded in cells 
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Figure 1. HIF-1 mediates the hypoxic up-regulation of Dll4 and Jag1 in macrophages. (a) Graphs showing time-course analysis of the effects of hypoxia on HIF-1α 
protein levels and mRNA expression of Jag1 and Dll4 in U937 macrophages. In all cases, points in the graphs represent mean ± SEM (n > 3). *p < 0.05 vs time 0 h 
or vs macrophages in normoxia at the same time point. (b) Graphs showing mRNA expression of Dll4 and Jag1 and protein levels of HIF-1α in mock-transfected 
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vs the same group in normoxia; #p < 0.05 vs mock-transfected cells in hypoxia. (c) Representative chromatin immunoprecipitation (ChIP) experiment performed 
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expressing CD206 (Figure 5a) and these values were similar between 
macrophages obtained from control and CD patients (Figure 5a).
3.4. Macrophages modulate Notch signalling and 
markers of differentiation in human intestine in a 
phenotype-dependent manner
To determine whether macrophages in the mucosa modulate Notch 
signalling in epithelial cells, we analysed this pathway specifically in 
crypts isolated from the mucosa of control and CD patients. Results 
revealed low HES1 immunostaining and decreased mRNA and pro-
tein HES1 expression in the mucosa of CD patients compared with 
controls (Figure 6a). In addition, we also detected enhanced Math1 
mRNA expression, increased Muc2 mRNA expression, a higher 
percentage of goblet cells per crypt and decreased IAP protein lev-
els in the mucosa of chronic CD patients compared with control 
mucosa, suggesting a diminution of the Notch signalling pathway 
and impaired differentiation associated with CD. To study a possi-
ble regulatory link between M1 macrophages and Notch signalling, 
the relationship between HES1 protein levels detected by western 
blot and the proportion of CD86+/CD68+ macrophages was ana-
lysed and a positive correlation coefficient (r = 0.4631, p = 0.045) 
(Figure  5d) was obtained. A  detailed analysis revealed a different 
distribution of points marked by the presence of CD, and when 
data were analysed separately the correlation coefficient was closer 
for both controls (r = 0.89, p = 0.001) and CD patients (r = 0.79, 
p = 0.001). This suggests that other factors were regulating HES1 in 
the mucosa (Figure 5d). Interestingly, a better correlation coefficient 
(r = 0.804, p < 0.001) was obtained between HES1 protein levels and 
the ratio of CD86+ (M1) to CD206+ (M2) macrophages (Figure 6e). 
The M1/M2 ratio also exhibited a positive and significant correla-
tion with IAP protein levels (r = 0.66, p = 0.002) (Figure 6e), which 
suggests that both M1 and M2 macrophages regulate Notch signal-
ling in the mucosa.
4. Discussion
The present study demonstrates that M1 macrophages, but not M2 
macrophages, are associated with HIF-1-dependent induction of 
Jag1 and Dll4, which increases HES1 protein levels and IAP activity 
in co-cultured epithelial cells. In the mucosa of chronic CD patients, 
the M1/M2 macrophage ratio closely correlates with Notch signal-
ling and markers of enterocyte differentiation, suggesting that mac-
rophages play a role in the diminished Notch signalling and impaired 
enterocyte differentiation observed.
Our data show that HIF-1, a transcription factor induced by 
hypoxia and inflammatory conditions, mediates the expression of 
Dll4 and Jag1 in hypoxic macrophages. A previous study reported 
activation of the Dll4 promoter by HIF-1 in endothelial cells.29 We 
demonstrate for the first time the activation of the Jag1 promoter 
by HIF-1 and provide further evidence that HIF-1 regulates the 
expression of Notch ligands. Emerging evidence suggests that the 
functional phenotype of macrophages is regulated by transcription 
factors that define alternative activation.18 We found HIF-1α stabili-
zation in human macrophages polarized towards an M1 phenotype 
and HIF-2α stabilization in those that had been polarized towards 
an M2 phenotype. Of interest, our data associate for the first time 
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Figure  2. HIF-1 mediates the expression of Notch ligands associated with M1 macrophages. U937-derived macrophages (n  =  6) were either treated with 
lipopolysaccharide (LPS) and interferon-γ (IFN-γ) and polarized towards M1 macrophages or treated with interleukin 4 (IL-4) and polarized towards M2 
macrophages; some cells were treated with the vehicle (non-polarized macrophages). (a) Representative Western blots and graph showing HIF-1α or HIF-2α 
protein levels at different time points. Points in the graphs represent mean ± SEM (n > 3). *p < 0.05 vs time 0 h. (b) Graphs show relative mRNA expression levels 
of Dll4 and Jag1 in macrophages and protein levels of Jag1 in M1 macrophages at different time points. Bars represent mean ± SEM. *p < 0.05 vs the respective 
value in non-polarized macrophages and M2 macrophages. (c). Graphs showing relative mRNA expression levels of Dll4 and Jag1 in macrophages derived 
from primary monocytes (healthy donors, n = 6; Crohn’s disease patients, n = 6). Bars represent mean ± SEM. *p < 0.05 vs the respective value in non-polarized 
macrophages and M2 macrophages. (d) Representative Western blots and graphs showing protein levels of HIF-1α and mRNA expression of Dll4 and Jag1 in 
U937-derived macrophages transfected with mock or miHIF-1α and polarized towards M1. Bars represent mean ± SEM. *p < 0.05 vs mock M1 macrophages.
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M1, but not M2, macrophages with HIF-1-dependent increases in 
the mRNA expression of Dll4 and Jag1, which suggests that this 
transcription factor mediates the selective Notch ligand expression 
that characterizes the macrophage phenotype. These effects have 
also been observed in macrophages derived from primary mono-
cytes obtained from both healthy subjects and CD patients properly 
polarized, supporting the idea of preferential expression of Notch 
ligands by the M1 phenotype. The pattern of Notch ligand expres-
sion is functionally relevant since M1, and not M2, macrophages 
increased the expression of the main target gene of the canonical 
Notch signalling, HES1, in epithelial cells in co-culture through an 
action mediated by the HIF-1-dependent induction of Jag1 and Dll4. 
This was observed in two epithelial cell lines capable of expressing 
differentiation features characteristic of mature intestinal cells, such 
as enterocytes or mucus cells.30, 31 In line with this, the increase in 
HES1 induced by M1 macrophages was paralleled by an increase 
in IAP activity, a well-known marker of enterocyte differentiation,32 
with no changes in Muc2 expression. Considering that our results 
show that spontaneous differentiation of these cells is associated 
with a time-dependent increase in both IAP activity and HES1 pro-
tein level, our results strongly suggest that M1 macrophages pro-
mote enterocyte differentiation in epithelial cells. Previous studies 
have shown that Jag1 up-regulates alkaline phosphatase in stem 
cells,33 which leads us to propose that M1 macrophages activate the 
Notch signalling pathway and enterocyte differentiation in epithelial 
cells through the expression of Dll4 and Jag1.
We analysed the pathophysiological relevance of these observa-
tions in the mucosa of CD patients, in which we found an increased 
number of macrophages compared with that of control patients. The 
expression of both M1 and M2 markers was detected but, in a simi-
lar manner to that previously reported in the mucosa of ulcerative 
colitis patients,26 the number of M2 macrophages was higher than 
the number of M1 macrophages. Of interest, a high percentage of 
M1 macrophages were positive for HIF-1α and Jag1, reinforcing 
the observations reported in vitro and suggesting that the expres-
sion of Notch ligands by M1 macrophages in human intestine is 
also associated with HIF-1. Of particular interest, macrophages were 
frequently detected in an adjacent position to epithelial cells and we 
observed a positive and significant correlation between CD86+ cells 
and HES1 protein levels in crypts isolated from the mucosa, which 
strongly supports the idea that M1 macrophages activate Notch sig-
nalling pathways in epithelial cells. A detailed analysis of this cor-
relation revealed differences in the distribution of data marked by 
the presence or absence of CD; a higher number of macrophages and 
lower protein levels of epithelial HES1 were detected in the mucosa 
of CD patients compared with control patients. These observations 
led us to suggest that, in addition to M1 macrophages, HES1 expres-
sion was modulated by other factors present in the inflamed mucosa. 
Considering our data showing that M2 macrophages prevail in the 
mucosa of CD patients and that most of them express HIF-2α, which 
has been related to Notch signalling inhibition,34 the results suggest 
that M2 macrophages may also be modulating the Notch pathway. 
Reinforcing this observation, we have previously demonstrated that 
M2 macrophages activate Wnt signalling in epithelial cells,26 and this 
pathway has been widely associated with inhibition of Notch signal-
ling.35–37 In line with this, our data show a very good correlation 
between HES1 protein levels and the ratio of M1/M2 macrophages, 
and we propose that M2 macrophages act in an opposite manner to 
M1 cells in the modulation of Notch signalling.
The Notch pathway governs the intestinal binary cell-fate deci-
sion between the secretory and absorptive cell lineages 38. Our 
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Figure  3. M1 macrophages activate HES1 expression and markers of 
differentiation in epithelial cells. HT29 cells (a) or Caco-2 cells (b) at pre-
confluence were co-cultured (24 h) with M1 or M2 macrophages (stained 
with CD18 and fluorescein isothiocyanate). In some cases macrophages 
were transfected with mock, miHIF1α, miDll4 or miJag1 vectors previous M1 
polarization. Levels of HES1 staining (TR) or Muc2 staining (TR) in epithelial 
cells were determined by static cytometry (n = 6). Graphs show a significant 
increase in the expression of epithelial HES1 induced by M1 but not M2 
macrophages compared with that detected in epithelial cells cultured alone. 
M1- miHIF1α, M1- miDll4, M1- miJag1 macrophages significantly reduced 
HES1 expression in either HT29 or Caco-2 cells. M1 or M2 macrophages 
failed to significantly modify the expression of Muc2 in either HT29 or Caco-2 
cells. IAP enzymatic activity in epithelial cells was significantly increased 
by M1 macrophages and significantly reduced by M2 macrophages. In ars 
represent mean ± SEM. *p < 0.05 and **p < 0.01 vs epithelial cells; #p < 0.05 
and ###p < 0.001 vs epithelial cells co-cultured with M1-mock macrophages.
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results reveal diminished HES1 expression in crypts isolated from 
the mucosa of CD patients in parallel with enhanced expression of 
Math1, a transcription factor that is repressed by HES1, strongly 
suggesting that the Notch signalling pathway was impaired.13 It has 
been reported that the up-regulation of Math 1 directs epithelial cell 
fate towards secretory lineage cells, including goblet cells.7, 39 Our 
data demonstrate increased mRNA expression of Muc2, a marker of 
goblet cells, and a higher number of goblet cells per crypt, in paral-
lel with decreased IAP protein levels in the mucosa of CD patients 
compared with controls, suggesting that enterocyte differentiation is 
specifically impaired. Previous studies have reported diminished IAP 
mRNA and protein expression40,41 in the intestinal mucosa of adults 
and children with CD. We extend these observations and show 
that these diminished IAP protein levels correlate with diminished 
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Figure 6. The M1/M2 ratio correlates with HES1 and IAP protein levels in human intestinal mucosa. (a) Representative Western blots showing HES1 and IAP 
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HES1 protein levels, which leads us to propose that enterocyte dif-
ferentiation is impaired in CD as a consequence of an undermined 
Notch signalling pathway. This hypothesis is backed by the fact 
that macrophages, which were closely correlated with HES1 pro-
tein levels, were also correlated with the expression of the enterocyte 
marker IAP.
As a whole, our results provide evidence of HIF-1 dependent 
induction of Notch ligands associated with M1 macrophages. In 
contrast to M2 macrophages, M1 cells activate the Notch signal-
ling pathway in epithelial cells. The prevalence of M2 over M1 mac-
rophages in the mucosa of chronic CD patients may mediate the 
diminished enterocyte differentiation and impaired mucosal regen-
eration observed in these patients. A  better understanding of the 
reciprocal regulation of macrophage phenotype and mucosal repair 
following intestinal damage will help to establish new approaches 
to CD therapy.
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